Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Number of holders
-
562
-
Total 13F shares, excl. options
-
254,419,132
-
Shares change
-
-4,154,838
-
Total reported value, excl. options
-
$9,679,406,899
-
Value change
-
-$220,838,009
-
Put/Call ratio
-
35%
-
Number of buys
-
239
-
Number of sells
-
326
-
Price
-
$38.02
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2022
As of 30 Sep 2022 Sanofi - Common Stock and American Depositary Receipts (SNY) had 562 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 254,419,132 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, Boston Partners, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BANK OF AMERICA CORP /DE/, BlackRock Inc., Camber Capital Management LP, MORGAN STANLEY, and Invesco Ltd..
This table shows 563 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.